Echtzeit-Aktienkurs iBio Inc.
Bid:
Ask:
Echtzeit-Chart der iBio Inc. Aktie
Fundamentaldaten der iBio Inc. Aktie
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2017 [USD] | 0,39 Mio. | -16,14 Mio. | -14,53 Mio. | - | - | - | - |
| 2016 [USD] | 0,95 Mio. | -10,66 Mio. | -9,76 Mio. | - | - | - | - |
| 2015 [USD] | 1,85 Mio. | -6,63 Mio. | -6,63 Mio. | - | - | - | - |
| 2014 [USD] | 0,20 Mio. | -3,67 Mio. | -3,67 Mio. | - | - | - | - |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. |
Profil der iBio Inc. Aktie
iBio, Inc. operates as a biotechnology company which focuses on commercializing its proprietary technology, iBioLaunch and iBioModulator, and developing product candidates derived from these platforms. iBioLaunch is a proprietary, transformative platform technology for development and production of biologics using transient gene expression in hydroponically grown, unmodified green plants. iBioModulator is a proprietary technology platform that is designed to improve the potency and duration of effect of both prophylactic and therapeutic vaccines produced with any recombinant expression technology including iBioLaunch. The company was founded on April 15, 1993 and is headquartered in Newark, DE.